Aralez Bio is a platform technology company with a proprietary enzymatic approach for designing and manufacturing noncanonical amino acids (ncAAs). The platform is expanding the amino acid toolbox 1000-fold, creating building blocks that drive next-generation products.
Market
Pharmaceuticals
Location
San Leandro,
California,
USA
Coinvestors
Paladin Capital Group, Good Growth Capital, Astia Ventures, Heritage Medical Systems, Freeflow Ventures, Impact Science Ventures, Juniper, Pineapple Group